Facility
Astellas Toyama Tacrolimus Manufacturing
Astellas Toyama facility manufactures tacrolimus API via Streptomyces fermentation; the Toyama/Hokuriku region is Japan's pharmaceutical manufacturing heartland; tacrolimus fermentation requires precise bioreactor conditions — scale-up is technically challenging, limiting the number of viable API manufacturers globally
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories